AI Den-Mab LLC
CIK: 0002132038
Transaction Breakdown
Open Market Buys (P)0
High conviction signal
Open Market Sales (S)0
Position reduction
Option Exercises (M)0
Derivative conversions
Awards (A)0
Compensation grants
Other (G, F, J, C, D, …)0
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
COAG
Hemab Therapeutics Holdings, Inc.
10% Owner
Discretionary Trading P&L
Holdings
Transaction History (0 total)
1 Form 3 filing on record — initial statements of ownership, which report holdings, not trades. No Form 4 or Form 5 transactions since Sep 2024.
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| 1 Form 3 filing on record — initial statements of ownership, which report holdings, not trades. No Form 4 or Form 5 transactions since Sep 2024. | ||||||
0-0 of 0 transactions
About AI DEN-MAB LLC
AI DEN-MAB LLC (SEC CIK 0002132038) files insider reports with the SEC as 10% Owner of Hemab Therapeutics Holdings, Inc. (COAG).
Signal8 holds 1 ownership filing by AI DEN-MAB LLC, a Form 3, filed on May 14, 2026. A Form 3 is an initial statement of ownership: it reports holdings, not trades, so no Form 4 or Form 5 transactions are on record since Sep 2024.
The business address on AI DEN-MAB LLC's filings is in NEW YORK, NY.
Other insiders filing for Hemab Therapeutics Holdings, Inc. (COAG)
- Walbert Keli, Director
- RA CAPITAL MANAGEMENT, L.P., 10% Owner
- Novo Holdings A/S, 10% Owner
- MARAGANORE JOHN, Director
- Madigan Catherine, Chief Medical Officer
- Behrndt-Eriksen Mads Nikolaj